Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study.
Amini AE, Hunter AE, Almashad A, Feng AJ, Patel ND, O'Dea MR, McCormick SR, Rodgers LH, Salari K. Amini AE, et al. Among authors: hunter ae. Eur Urol Oncol. 2024 Mar 6:S2588-9311(24)00041-5. doi: 10.1016/j.euo.2024.01.015. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38453598 Free article.
Reply by Authors.
Moses RA, Hunter AE, Brandes ER, Zhang Z, Rees JR, Peacock JL, Bihrle W 3rd, Sethuraman K, Weaver LK, Buckey JC Jr. Moses RA, et al. Among authors: hunter ae. J Urol. 2024 Jun;211(6):774. doi: 10.1097/JU.0000000000003955. Epub 2024 Apr 9. J Urol. 2024. PMID: 38721933 No abstract available.
Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets.
van der Meulen T, Mawla AM, DiGruccio MR, Adams MW, Nies V, Dólleman S, Liu S, Ackermann AM, Cáceres E, Hunter AE, Kaestner KH, Donaldson CJ, Huising MO. van der Meulen T, et al. Among authors: hunter ae. Cell Metab. 2017 Apr 4;25(4):911-926.e6. doi: 10.1016/j.cmet.2017.03.017. Cell Metab. 2017. PMID: 28380380 Free PMC article.
Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.
Burnett AK, Russell NH, Hunter AE, Milligan D, Knapper S, Wheatley K, Yin J, McMullin MF, Ali S, Bowen D, Hills RK; UK National Cancer Research Institute AML Working Group. Burnett AK, et al. Among authors: hunter ae. Blood. 2013 Aug 22;122(8):1384-94. doi: 10.1182/blood-2013-04-496596. Epub 2013 Jul 9. Blood. 2013. PMID: 23838349 Free article. Clinical Trial.
An unusual cause of Grey Turner's sign.
Gosling OB, Hunter AE, Edwards GA, Squires B. Gosling OB, et al. Among authors: hunter ae. BMJ Case Rep. 2013 May 15;2013:bcr2013008836. doi: 10.1136/bcr-2013-008836. BMJ Case Rep. 2013. PMID: 23682085 Free PMC article.
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison.
Burnett AK, Hills RK, Hunter AE, Milligan D, Kell WJ, Wheatley K, Yin J, McMullin MF, Dignum H, Bowen D, Russell NH; UK National Cancer Research Institute AML Working Group. Burnett AK, et al. Among authors: hunter ae. Leukemia. 2013 Jan;27(1):75-81. doi: 10.1038/leu.2012.229. Epub 2012 Aug 14. Leukemia. 2013. PMID: 22964882 Clinical Trial.
36 results